Stelmakh Edward bought OPRX
October 3, 2025 · Form 4 insider transaction
Stelmakh Edward bought 16,623 shares of OptimizeRx Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,623
Price
$0.00
Total value
N/A
InsiderStelmakh Edward
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 3, 2025
Filing dateOctober 7, 2025
Shares owned after127,387
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units convert into common stock on a one-for-one basis.